EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

GSH-Responsive PBAE Polymers for IL-12 mRNA Delivery in Melanoma Immunotherapy

Xiaoli Bao, Zhihui Xu, Xi Wang, Te Zhang, Huijing Ye, Huasheng Yang

Investigative Ophthalmology & Visual Science · 2026-05-20 · 67 (5) · 57

DOI: 10.1167/iovs.67.5.57 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2026-05-20. Written by Xiaoli Bao and 5 co-authors. Institution: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Major MEDLINE topics: RNA, Messenger, Interleukin-12, Immunotherapy, Glutathione. Cited 1 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Melanoma is a highly aggressive cancer with significant treatment challenges due to its immunosuppressive tumor microenvironment. Among its subtypes, uveal melanoma (UM), as a distinct subtype arising in the immune-privileged ocular site, currently lacks effective therapies to improve overall survival.

Methods

We developed a glutathione (GSH)-responsive poly(β-amino ester) (PBAE) platform for intracellular IL-12 mRNA delivery. By optimizing the ratio of GSH-responsive diacrylate monomers and amine structures, we synthesized and screened a library of candidate polymers for transfection efficiency. Nanoparticle size, stability, GSH-triggered disassembly, and mRNA release were characterized. Cellular uptake, protein expression, endo/lysosomal escape, cytotoxicity, and systemic safety were assessed in vitro and in vivo. Efficacy was evaluated in subcutaneous, intraocular, and lung metastasis mouse models using the B16F10 melanoma cell line.

Results

The optimized polymer PSS0.5-A2B2 formed stable mRNA-loaded nanoparticles (approximately 100 nm) and exhibited time-dependent disassembly under GSH-rich conditions, enabling efficient mRNA release and enhanced IL-12 expression. In vitro, it enhanced cellular uptake, IL-12 expression, and endo/lysosomal escape. In vivo, no significant systemic toxicity was observed. IL-12 mRNA delivery significantly suppressed tumor growth, promoted apoptosis, and reduced metastasis. Combined intravitreal and intravenous administration showed superior antitumor efficacy.

Conclusions

This GSH-responsive PBAE platform enables biocompatible intracellular IL-12 mRNA delivery, offering a promising local-systemic combinatorial immunotherapy strategy for melanoma, holding potential promise for UM.

Subjects

MeSH terms (MEDLINE)

RNA, MessengerInterleukin-12ImmunotherapyGlutathionePolymersMelanomaMelanoma, ExperimentalUveal NeoplasmsAnimalsMiceMice, Inbred C57BLNanoparticlesHumansCell Line, TumorFemale

Substances

RNA, MessengerInterleukin-12GlutathionePolymers

Authors and institutions

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, People's Republic of China.

Cite

APA

Bao, X., Xu, Z., Wang, X., Zhang, T., Ye, H., & Yang, H. (2026). GSH-Responsive PBAE Polymers for IL-12 mRNA Delivery in Melanoma Immunotherapy. Investigative Ophthalmology & Visual Science, 67(5), 57. https://doi.org/10.1167/iovs.67.5.57

Vancouver

Bao X, Xu Z, Wang X, Zhang T, Ye H, Yang H. GSH-Responsive PBAE Polymers for IL-12 mRNA Delivery in Melanoma Immunotherapy. Investigative Ophthalmology & Visual Science. 2026;67(5):57. doi:10.1167/iovs.67.5.57

BibTeX
@article{Bao2026,
  author = {Bao, Xiaoli and Xu, Zhihui and Wang, Xi and Zhang, Te and Ye, Huijing and Yang, Huasheng},
  title = {GSH-Responsive PBAE Polymers for IL-12 mRNA Delivery in Melanoma Immunotherapy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  volume = {67},
  number = {5},
  pages = {57},
  doi = {10.1167/iovs.67.5.57}
}
Start for free →